Vanda Pharmaceuticals
VNDA
$4.62
Share price
3.12%
Change (1 day)
-24.76%
Change (1 year)
Categories
P/S ratio for Vanda Pharmaceuticals (VNDA)
P/S ratio as of April 2024 (TTM): 1.38
According to Vanda Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.3799. At the end of 2023 the company had a P/S ratio of 1.26.
P/S ratio history for Vanda Pharmaceuticals from 2010 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.26 | -23.34% |
| 2022 | 1.64 | -49.47% |
| 2021 | 3.25 | 11.99% |
| 2020 | 2.90 | -24.9% |
| 2019 | 3.87 | -45.53% |
| 2018 | 7.10 | 71.65% |
| 2017 | 4.14 | -13.83% |
| 2016 | 4.80 | 32.38% |
| 2015 | 3.63 | -69.39% |
| 2014 | 11.8 | -3.01% |
| 2013 | 12.2 | 282.47% |
| 2012 | 3.19 | -25.4% |
| 2011 | 4.28 | -42.38% |
| 2010 | 7.43 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.79 | 174.36% | 🇺🇸 USA |
 Novartis NVS | 4.01 | 190.46% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.46 | 78.18% | 🇺🇸 USA |
 Eli Lilly LLY | 20.4 | 1,381.06% | 🇺🇸 USA |
 Merck MRK | 5.53 | 300.64% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.00 | 44.67% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | > 1000 | 469,638.39% | 🇺🇸 USA |